» Articles » PMID: 30744875

Dermatologic Care for Lesbian, Gay, Bisexual, and Transgender Persons: Epidemiology, Screening, and Disease Prevention

Overview
Specialty Dermatology
Date 2019 Feb 13
PMID 30744875
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Lesbian, gay, bisexual, and transgender (LGBT) persons face important health issues relevant to dermatologists. Men who have sex with men (MSM) are at higher risk of certain infectious diseases, including HIV, syphilis and other sexually transmitted diseases (STDs), methicillin-resistant Staphylococcus aureus infections, and invasive meningococcal disease, and might be at higher risk of non-infectious conditions, including skin cancer. Recommendations for preventive health care, including screening for HIV and other STDs, sexual health-related vaccinations, and HIV pre-exposure prophylaxis, differ for MSM compared with non-MSM. Women who have sex with women experience disparities in STDs, including chlamydia and HPV. Transgender patients have unique, and often unmet, dermatologic needs during gender transition (also called gender affirmation), related to hormonal therapy and gender-affirming surgery. Familiarity with LGBT health issues and disease-prevention guidelines can enable dermatologists to provide medically appropriate and culturally competent care to LGBT persons.

Citing Articles

Attitudes, practices, facilitators, and barriers to sexual orientation and gender identity data collection in dermatology practices.

Chen R, Adekunle T, Chu L, Festok R, Gao J, Yanes D Arch Dermatol Res. 2024; 316(9):663.

PMID: 39369135 DOI: 10.1007/s00403-024-03377-3.


There Exist Educational Deficiencies in Specialized Dermatologic Care: Implications for Patients of Different Sexes, Genders, and Sexual Orientations.

Mark I, Diaz M, Tran J, Lipner S Dermatol Pract Concept. 2024; 14(2).

PMID: 38810032 PMC: 11135945. DOI: 10.5826/dpc.1402a128.


Aesthetic Considerations for Treating Lesbian, Gay, and Bisexual Patients: A Review and Our Experience.

Hennessy K, Dayan S, Somenek M, Bay S, Witfill K, Fabi S J Clin Aesthet Dermatol. 2024; 17(5):34-39.

PMID: 38779371 PMC: 11107904.


Facilitators and Barriers of HPV Vaccine Acceptance, Initiation, and Completion among LGBTQ Community in the U.S.: A Systematic Review.

Hao Z, Guo Y, Bowling J, Ledenyi M Int J Sex Health. 2024; 34(2):291-307.

PMID: 38596525 PMC: 10903696. DOI: 10.1080/19317611.2021.1989535.


Embracing Spectrum: Celebrating LGBTQIA+ Journeys in Aesthetic Medicine: A Kaleidoscope of Identity.

Rahman E, Rao P, Webb W, Philipp-Dormston W, Sayed K, Almeida A Aesthetic Plast Surg. 2024; 48(15):2902-2914.

PMID: 38499877 DOI: 10.1007/s00266-024-03923-4.


References
1.
Siegler A, Wirtz S, Weber S, Sullivan P . Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures. JMIR Public Health Surveill. 2017; 3(3):e58. PMC: 5607436. DOI: 10.2196/publichealth.7902. View

2.
. Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations--five cities, United States, 2007. MMWR Morb Mortal Wkly Rep. 2009; 58(26):716-9. View

3.
Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S . Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371(9630):2109-19. PMC: 2650104. DOI: 10.1016/S0140-6736(08)60920-4. View

4.
Benotsch E, Zimmerman R, Cathers L, Pierce J, McNulty S, Heck T . Non-medical use of prescription drugs and HIV risk behaviour in transgender women in the Mid-Atlantic region of the United States. Int J STD AIDS. 2015; 27(9):776-82. DOI: 10.1177/0956462415595319. View

5.
Irwig M . Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 2016; 5(4):301-311. DOI: 10.1016/S2213-8587(16)00036-X. View